The dosage typically starts at 0.25 mg weekly and gradually increases to a maintenance dose of up to 2.4 mg, depending on individual response
Do not combine BPC-157 with prescription sleep medications (zolpidem, eszopiclone, benzodiazepines) without medical supervision
Your prescriber will weigh efficacy, diabetes status, and personal risk factors
You might be a suitable candidate if: BMI Consideration : You have a body mass index (BMI) of 30 or greater, classifying you as medically obese, or a BMI of 27 or greater with at least one weight-related health condition like hypertension, type 2 diabetes, or high cholesterol
Some patients may stay on their maintenance dose indefinitely, while others, under the guidance of their provider, may eventually test a lower holding dose to maintain their results
What were talking about is between two to 18 additional cases of NAION per 100,000 GLP-1 users per year, she said